In today’s era, vegetables are considered a very important part of many foods. Even though every individual can harvest their vegetables in the home kitchen garden, in vegetable crops, Tomatoes are the most popular and can be used normally in every kind of food item. Tomato plants get affected by various diseases during their growing season, like many other crops. Normally, in tomato plants, 40–60% may be damaged due to leaf diseases in the field if the cultivators do not focus on control measures. In tomato production, these diseases can bring a great loss. Therefore, a proper mechanism is needed for the detection of these problems. Different techniques were proposed by researchers for detecting these plant diseases and these mechanisms are vector machines, artificial neural networks, and Convolutional Neural Network (CNN) models. In earlier times, a technique was used for detecting diseases called the benchmark feature extraction technique. In this area of study for detecting tomato plant diseases, another model was proposed, which was known as the real-time faster region convolutional neural network (RTF-RCNN) model, using both images and real-time video streaming. For the RTF-RCNN, we used different parameters like precision, accuracy, and recall while comparing them with the Alex net and CNN models. Hence the final result shows that the accuracy of the proposed RTF-RCNN is 97.42%, which is higher than the rate of the Alex net and CNN models, which were respectively 96.32% and 92.21%.

Cardiovascular disease includes coronary artery diseases (CAD), which include angina and myocardial infarction (commonly known as a heart attack), and coronary heart diseases (CHD), which are marked by the buildup of a waxy material called plaque inside the coronary arteries. Heart attacks are still the main cause of death worldwide, and if not treated right they have the potential to cause major health problems, such as diabetes. If ignored, diabetes can result in a variety of health problems, including heart disease, stroke, blindness, and kidney failure. Machine learning methods can be used to identify and diagnose diabetes and other illnesses. Diabetes and cardiovascular disease both can be diagnosed using several classifier types. Naive Bayes, K-Nearest neighbor (KNN), linear regression, decision trees (DT), and support vector machines (SVM) were among the classifiers employed, although all of these models had poor accuracy. Therefore, due to a lack of significant effort and poor accuracy, new research is required to diagnose diabetes and cardiovascular disease. This study developed an ensemble approach called “Stacking Classifier” in order to improve the performance of integrated flexible individual classifiers and decrease the likelihood of misclassifying a single instance. Naive Bayes, KNN, Linear Discriminant Analysis (LDA), and Decision Tree (DT) are just a few of the classifiers used in this study. As a meta-classifier, Random Forest and SVM are used. The suggested stacking classifier obtains a superior accuracy of 0.9735 percent when compared to current models for diagnosing diabetes, such as Naive Bayes, KNN, DT, and LDA, which are 0.7646 percent, 0.7460 percent, 0.7857 percent, and 0.7735 percent, respectively. Furthermore, for cardiovascular disease, when compared to current models such as KNN, NB, DT, LDA, and SVM, which are 0.8377 percent, 0.8256 percent, 0.8426 percent, 0.8523 percent, and 0.8472 percent, respectively, the suggested stacking classifier performed better and obtained a higher accuracy of 0.8871 percent.

Bioinformatics and genomics are driving a healthcare revolution, particularly in the domain of drug discovery for anticancer peptides (ACPs). The integration of artificial intelligence (AI) has transformed healthcare, enabling personalized and immersive patient care experiences. These advanced technologies, coupled with the power of bioinformatics and genomic data, facilitate groundbreaking developments. The precise prediction of ACPs from complex biological sequences remains an ongoing challenge in the genomic area. Currently, conventional approaches such as chemotherapy, target therapy, radiotherapy, and surgery are widely used for cancer treatment. However, these methods fail to completely eradicate neoplastic cells or cancer stem cells and damage healthy tissues, resulting in morbidity and even mortality. To control such diseases, oncologists and drug designers highly desire to develop new preventive techniques with more efficiency and minor side effects. Therefore, this research provides an optimized computational-based framework for discriminating against ACPs. In addition, the proposed approach intelligently integrates four peptide encoding methods, namely amino acid occurrence analysis (AAOA), dipeptide occurrence analysis (DOA), tripeptide occurrence analysis (TOA), and enhanced pseudo amino acid composition (EPseAAC). To overcome the issue of bias and reduce true error, the synthetic minority oversampling technique (SMOTE) is applied to balance the samples against each class. The empirical results over two datasets, where the accuracy of the proposed model on the benchmark dataset is 97.56% and on the independent dataset is 95.00%, verify the effectiveness of our ensemble learning mechanism and show remarkable performance when compared with state-of-the-art (SOTA) methods. In addition, the application of metaverse technology in healthcare holds promise for transformative innovations, potentially enhancing patient experiences and providing novel solutions in the realm of preventive techniques and patient care.

Classification is a common problem in various fields of life, and the key challenging task in data mining. The primary objective of the classification process to classify the given dataset in a defined class label for all data. Many research papers widely used classification in the medical sector. Various researches have been carried out to classify medical data using different techniques, such as High Order Neural Network (HONN) combined with Back-Propagation Neural Network (BPNN) as a learning algorithm. Due to the increased data complexity, the back-propagation algorithm faced problems of slow convergence. The Back-Propagation (BP) using the gradient descent technique has the possibility of getting stuck in local minima. So, the BP algorithm may cause difficulties in finding the global minima of the error function. This paper proposed a high-order Functional Link Neural Network (FLNN). The proposed FLNN model is integrated with a metaheuristic-based searching algorithm called Accelerated Particle Swarm Optimization (APSO). The performance of the proposed Accelerated Particle Swarm Optimization Functional Link Neural Network (APSOFLNN) model is validated with various medical datasets and compared to traditional techniques such as the proposed Accelerated Particle Swarm Optimization Functional Link Back-Propagation (APSOFLBP), and Artificial Bee Colony Functional Link Neural Network (ABCFLNN). The simulation results showed that the proposed APSOFLNN algorithm for the used benchmarked datasets shows good results in terms of the mean square error (MSE) and accuracy in comparison to the traditional techniques.